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HIV, genital herpes, and other sexually transmitted infec-
tions are a critical national and global health priority
requiring the rapid development of safe and effective con-
trol methods. While condoms prevent HIV transmission,
social acceptance is a major barrier and consistent use is
difficult to achieve. Although there have been great strides
in vaccine development, a fully protective vaccine unlikely
to be available in the near future Thus, the development
of vaginal microbicides has emerged as a priority in the
effort to control the AIDS epidemic. An optimal microbi-
cide should protect against infection but must also be safe,
without adversely affecting the mucosal environment,
including mediators of host defense. Over sixty candidate
microbicides are in development and several are currently
being tested in Phase III clinical trials. However, critical
gaps in the preclinical and clinical development of micro-
bicides include the identification of optimal assays to pre-
dict efficacy and safety. Identification of in vitro, animal
model or pilot clinical assays that could serve as surrogate
markers to predict the extent of antimicrobial activity and
the safety of microbicides prior to embarking on large-
scale clinical trials are urgently needed. This will require a
greater understanding of mucosal immunity and the viral
and host factors that contribute to infection in the female
genital tract.
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